AVBP logo

ArriVent BioPharma (AVBP) Cash From Investing

Annual CFI

-$192.47 M
-$192.47 M-100.00%

December 31, 2024


Summary


Performance

AVBP Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAVBPcash flowmetrics:

Quarterly CFI

-$192.47 M
-$192.47 M-100.00%

December 31, 2024


Summary


Performance

AVBP Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAVBPcash flowmetrics:

TTM CFI

-$192.47 M
-$217.47 M-869.86%

December 31, 2024


Summary


Performance

AVBP TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAVBPcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

AVBP Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-100.0%-100.0%-869.9%
3 y3 years--100.0%-869.9%
5 y5 years--100.0%-869.9%

AVBP Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year<-9999.0%at low-869.9%at low-869.9%at low
5 y5-year<-9999.0%at low-869.9%at low-869.9%at low
alltimeall time<-9999.0%at low-869.9%at low-869.9%at low

ArriVent BioPharma Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2024
-$192.47 M(<-9900.0%)
-$192.47 M(<-9900.0%)
-$192.47 M(-869.9%)
Sep 2024
-
$0.00(0.0%)
$25.00 M(0.0%)
Jun 2024
-
$0.00(-100.0%)
$25.00 M(>+9900.0%)
Dec 2023
$0.00
$25.00 M(>+9900.0%)
$0.00(-100.0%)
DateAnnualQuarterlyTTM
Sep 2023
-
$0.00(-100.0%)
-$25.00 M(0.0%)
Jun 2023
-
-$25.00 M(<-9900.0%)
-$25.00 M(<-9900.0%)
Dec 2022
$0.00
-
-
Sep 2022
-
$0.00
$0.00

FAQ

  • What is ArriVent BioPharma annual cash flow from investing activities?
  • What is the all time high annual CFI for ArriVent BioPharma?
  • What is ArriVent BioPharma annual CFI year-on-year change?
  • What is ArriVent BioPharma quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for ArriVent BioPharma?
  • What is ArriVent BioPharma quarterly CFI year-on-year change?
  • What is ArriVent BioPharma TTM cash flow from investing activities?
  • What is the all time high TTM CFI for ArriVent BioPharma?
  • What is ArriVent BioPharma TTM CFI year-on-year change?

What is ArriVent BioPharma annual cash flow from investing activities?

The current annual CFI of AVBP is -$192.47 M

What is the all time high annual CFI for ArriVent BioPharma?

ArriVent BioPharma all-time high annual cash flow from investing activities is $0.00

What is ArriVent BioPharma annual CFI year-on-year change?

Over the past year, AVBP annual cash flow from investing activities has changed by -$192.47 M (-100.00%)

What is ArriVent BioPharma quarterly cash flow from investing activities?

The current quarterly CFI of AVBP is -$192.47 M

What is the all time high quarterly CFI for ArriVent BioPharma?

ArriVent BioPharma all-time high quarterly cash flow from investing activities is $25.00 M

What is ArriVent BioPharma quarterly CFI year-on-year change?

Over the past year, AVBP quarterly cash flow from investing activities has changed by -$192.47 M (-100.00%)

What is ArriVent BioPharma TTM cash flow from investing activities?

The current TTM CFI of AVBP is -$192.47 M

What is the all time high TTM CFI for ArriVent BioPharma?

ArriVent BioPharma all-time high TTM cash flow from investing activities is $25.00 M

What is ArriVent BioPharma TTM CFI year-on-year change?

Over the past year, AVBP TTM cash flow from investing activities has changed by -$217.47 M (-869.86%)